{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:26:23Z","timestamp":1787837183217,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["113S538"],"award-info":[{"award-number":["113S538"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.actbio.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T04:15:48Z","timestamp":1473999348000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Regenerative effects of peptide nanofibers in an experimental model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Melike","family":"Sever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Turkyilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysen","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Ocalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Cansev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa O.","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse B.","family":"Tekinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2016.09.011_b0005","series-title":"Health at a Glance","author":"Union","year":"2010"},{"issue":"6","key":"10.1016\/j.actbio.2016.09.011_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"issue":"5646","key":"10.1016\/j.actbio.2016.09.011_b0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.actbio.2016.09.011_b0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0278-5846(03)00019-8","article-title":"Apoptosis and Parkinson\u2019s disease","volume":"27","author":"Lev","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2000.7489","article-title":"Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson\u2019s disease","volume":"166","author":"Tatton","year":"2000","journal-title":"Exp. Neurol."},{"issue":"Suppl. 3","key":"10.1016\/j.actbio.2016.09.011_b0030","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/ana.10489","article-title":"Apoptosis in Parkinson\u2019s disease: signals for neuronal degradation","volume":"53","author":"Tatton","year":"2003","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.actbio.2016.09.011_b0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009365","article-title":"Programmed cell death in Parkinson\u2019s disease","volume":"2","author":"Venderova","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.actbio.2016.09.011_b0040","article-title":"Targeting Caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson\u2019s disease","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ncl.2014.09.009","article-title":"Treatment strategies in early and advanced Parkinson disease","volume":"33","author":"Ossig","year":"2015","journal-title":"Neurol. Clin."},{"issue":"2","key":"10.1016\/j.actbio.2016.09.011_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2014.05.010","article-title":"Emerging therapies for Parkinson\u2019s disease: from bench to bedside","volume":"144","author":"Tarazi","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"9579","key":"10.1016\/j.actbio.2016.09.011_b0055","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2016.09.011_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-015-1400-1","article-title":"Stem cell transplantation therapy in Parkinson\u2019s disease","volume":"4","author":"Fu","year":"2015","journal-title":"Springerplus"},{"issue":"26","key":"10.1016\/j.actbio.2016.09.011_b0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1098\/rsif.2008.0071","article-title":"Biomaterials for the central nervous system","volume":"5","author":"Zhong","year":"2008","journal-title":"J. R. Soc. Interface"},{"issue":"11","key":"10.1016\/j.actbio.2016.09.011_b0070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1039\/c3bm60150a","article-title":"Neural differentiation on synthetic scaffold materials","volume":"1","author":"Mammadov","year":"2013","journal-title":"Biomater. Sci. UK"},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00441-009-0838-2","article-title":"Laminins","volume":"339","author":"Durbeej","year":"2010","journal-title":"Cell Tissue Res."},{"issue":"11","key":"10.1016\/j.actbio.2016.09.011_b0080","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/dneu.20950","article-title":"Integrins and the extracellular matrix: key mediators of development and regeneration of the sensory nervous system","volume":"71","author":"Gardiner","year":"2011","journal-title":"Dev. Neurobiol."},{"issue":"6","key":"10.1016\/j.actbio.2016.09.011_b0085","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1083\/jcb.97.6.1882","article-title":"Laminin promotes neuritic regeneration from cultured peripheral and central neurons","volume":"97","author":"Manthorpe","year":"1983","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.actbio.2016.09.011_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R","article-title":"Form and function: the laminin family of heterotrimers","volume":"218","author":"Colognato","year":"2000","journal-title":"Dev. Dyn."},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0006-8993(90)91324-A","article-title":"Functional interactions of neuronal heparan sulphate proteoglycans with laminin","volume":"525","author":"Riopelle","year":"1990","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.actbio.2016.09.011_b0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc842","article-title":"Roles of heparan-sulphate glycosaminoglycans in cancer","volume":"2","author":"Sasisekharan","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.actbio.2016.09.011_b0105","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jnr.490220308","article-title":"Evidence that the axolemmal mitogen for cultured schwann-cells is a positively charged, heparan-sulfate proteoglycan-bound, heparin-displaceable molecule","volume":"22","author":"Decoster","year":"1989","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.actbio.2016.09.011_b0110","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s10439-008-9575-z","article-title":"Control of growth factor networks by heparan sulfate proteoglycans","volume":"36","author":"Forsten-Williams","year":"2008","journal-title":"Ann. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.actbio.2016.09.011_b0115","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/glycob\/10.11.1183","article-title":"Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2","volume":"10","author":"Pye","year":"2000","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bip.21328","article-title":"Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials","volume":"94","author":"Cui","year":"2010","journal-title":"Biopolymers"},{"issue":"27","key":"10.1016\/j.actbio.2016.09.011_b0125","doi-asserted-by":"crossref","first-page":"16174","DOI":"10.1016\/S0021-9258(18)71604-9","article-title":"A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth","volume":"264","author":"Tashiro","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"5662","key":"10.1016\/j.actbio.2016.09.011_b0130","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1093783","article-title":"Selective differentiation of neural progenitor cells by high-epitope density nanofibers","volume":"303","author":"Silva","year":"2004","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.actbio.2016.09.011_b0135","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/jnr.22472","article-title":"Self-assembling peptide amphiphile promotes plasticity of serotonergic fibers following spinal cord injury","volume":"88","author":"Tysseling","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"14","key":"10.1016\/j.actbio.2016.09.011_b0140","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1523\/JNEUROSCI.0143-08.2008","article-title":"Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury","volume":"28","author":"Tysseling-Mattiace","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.actbio.2016.09.011_b0145","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.actbio.2012.02.006","article-title":"Cooperative effect of heparan sulfate and laminin mimetic peptide nanofibers on the promotion of neurite outgrowth","volume":"8","author":"Mammadov","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.09.011_b0150","series-title":"Atlas of the Developing Rat Nervous System","author":"Paxinos","year":"2013"},{"issue":"3","key":"10.1016\/j.actbio.2016.09.011_b0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neures.2008.07.005","article-title":"Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson\u2019s disease","volume":"62","author":"Cansev","year":"2008","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.actbio.2016.09.011_b0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.actbio.2016.09.011_b0165","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1460-9568.2000.00274.x","article-title":"Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor","volume":"12","author":"Kirik","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.actbio.2016.09.011_b0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-59259-691-1_8","article-title":"Intervention strategies for degeneration of dopamine neurons in Parkinsonism","author":"Schallert","year":"2000","journal-title":"Central nervous system diseases, Springer"},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.actbio.2016.09.011_b0180","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb Akinesia in the Rat Parkinson Model \u2013 Differential-Effects of Dopamine Agonists and Nigral Transplants as Assessed by a New Stepping Test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.actbio.2016.09.011_b0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson\u2019s disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.actbio.2016.09.011_b0190","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/S0021-9258(19)39691-7","article-title":"Heparin modulation of laminin polymerization","volume":"265","author":"Yurchenco","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.actbio.2016.09.011_b0195","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1529\/biophysj.105.073114","article-title":"Matrices with compliance comparable to that of brain tissue select neuronal over glial growth in mixed cortical cultures","volume":"90","author":"Georges","year":"2006","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"issue":"4\u20135","key":"10.1016\/j.actbio.2016.09.011_b0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0301-0082(95)00051-8","article-title":"The concept of microglia in relation to central nervous system disease and regeneration","volume":"48","author":"Moore","year":"1996","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.actbio.2016.09.011_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0173(92)90007-9","article-title":"Brain macrophages \u2013 evaluation of microglia and their functions","volume":"17","author":"Thomas","year":"1992","journal-title":"Brain Res. Rev."},{"issue":"5","key":"10.1016\/j.actbio.2016.09.011_b0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H","article-title":"Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro","volume":"43","author":"Hamanoue","year":"1996","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.actbio.2016.09.011_b0220","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/(SICI)1097-4547(19971215)50:6<1023::AID-JNR13>3.0.CO;2-5","article-title":"Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia","volume":"50","author":"Miwa","year":"1997","journal-title":"J. Neurosci. Res."},{"issue":"8","key":"10.1016\/j.actbio.2016.09.011_b0225","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.biocel.2013.06.005","article-title":"Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcgammaR I and TLR4 pathways","volume":"45","author":"Zhang","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116304743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116304743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:49:43Z","timestamp":1761670183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706116304743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":45,"alternative-id":["S1742706116304743"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2016.09.011","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regenerative effects of peptide nanofibers in an experimental model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}